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Abstract 
Background: Tumor targeting of radiotherapy represents a great challenge. The addition of multimodal nanoparti-
cles, such as 3 nm gadolinium-based nanoparticles (GdBNs), has been proposed as a promising strategy to amplify 
the effects of radiation in tumors and improve diagnostics using the same agents. This singular property named 
theranostic is a unique advantage of GdBNs. It has been established that the amplification of radiation effects by 
GdBNs appears due to fast electronic processes. However, the influence of these nanoparticles on cells is not yet 
understood. In particular, it remains dubious how nanoparticles activated by ionizing radiation interact with cells and 
their constituents. A crucial question remains open of whether damage to the nucleus is necessary for the radiosensi-
tization exerted by GdBNs (and other nanoparticles).
Methods: We studied the effect of GdBNs on the induction and repair of DNA double-strand breaks (DSBs) in the 
nuclear DNA of U87 tumor cells irradiated with γ-rays. For this purpose, we used currently the most sensitive method 
of DSBs detection based on high-resolution confocal fluorescence microscopy coupled with immunodetection of 
two independent DSBs markers.
Results: We show that, in the conditions where GdBNs amplify radiation effects, they remain localized in the cyto-
plasm, i.e. do not penetrate into the nucleus. In addition, the presence of GdBNs in the cytoplasm neither increases 
induction of DSBs by γ-rays in the nuclear DNA nor affects their consequent repair.
Conclusions: Our results suggest that the radiosensitization mediated by GdBNs is a cytoplasmic event that is 
independent of the nuclear DNA breakage, a phenomenon commonly accepted as the explanation of biological 
radiation effects. Considering our earlier recognized colocalization of GdBNs with the lysosomes and endosomes, we 
revolutionary hypothesize here about these organelles as potential targets for (some) nanoparticles. If confirmed, this 
finding of cytoplasmically determined radiosensitization opens new perspectives of using nano-radioenhancers to 
improve radiotherapy without escalating the risk of pathologies related to genetic damage.
Keywords: Radiosensitization, Nanomedicine, Gadolinium, Nanoparticles, DNA double-strand breaks, DNA repair, 
Radiotherapy, Theranostic
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Open Access
Journal of Nanobiotechnology
*Correspondence:  lenka.stefancikova@u-psud.fr; falk@ibp.cz 
1 Department of Cell Biology and Radiobiology, Institute of Biophysics 
of ASCR, Brno, Czech Republic
2 Institute des Sciences Moléculaires d’Orsay (ISMO), Université Paris Sud 
11, CNRS, Université Paris Saclay, Bât 351, 91405 Orsay Cedex, France
Full list of author information is available at the end of the article
Page 2 of 15Štefančíková et al. J Nanobiotechnol  (2016) 14:63 
Background
Radiation-based therapies are used to treat half of can-
cer patients. Most common treatments based on highly 
penetrating MeV photons (X-rays and γ-rays) have the 
advantage of being non-invasive and applicable on inop-
erable tumors. However, the photon radiotherapy suffers 
from a serious disadvantage—it lacks tumor specificity. 
Photons induce damage all along their tracks, inflicting 
thus severe side effects in the healthy tissue. On the other 
hand, some tumors are resistant to high-energy photons. 
Therefore, a simultaneous enhancement of tumor selec-
tivity and biological effectiveness of radiations is a long-
lasting objective of cancer radiotherapy.
Nanoparticles (NPs) composed of high-Z atoms have 
been proposed as new nanodrugs able to improve both 
these desired aspects of radiation-based therapies (speci-
ficity and efficiency). Results obtained with various NPs 
showed that they can specifically increase radiosensitiv-
ity of tumor cells [1–4]. The use of nano-size agents that 
preferentially accumulate in the tumor (even passively 
due to the enhanced permeability and retention effect, 
EPR) [5, 6] may achieve the paradigm of local treatment 
of solid tumors. Among metal-based NPs, gold NPs have 
been widely used for diagnostics as contrast agents, and 
for therapy as nano-enhancers of radiation effects [7–
11]. Gold NPs potentiate the effects of different photon 
beams, both in vivo and in vitro [1–4, 10, 12–14]. More 
recently, we have found [15, 16] that also platinum NPs 
enhance the effects of radiations, γ-rays as well as fast 
medical ions. Likewise, metal oxide nanoparticles are 
already on the market, currently evaluated in oncology 
clinical trials as compounds for tumor diagnostic and 
cancer treatment [17, 18].
An important step forward has been the development 
of gadolinium-based nanoparticles (GdBNs), which 
can act as multimodal agents and improve not only the 
therapeutic index of the treatment but also MRI perfor-
mance (theranostics) [19, 20]. Due to its atomic mass 
(Z  =  64), gadolinium is a good electron emitter, which 
is the property required to enhance the radiation effects. 
When applied in combination with both low and high-
energy X-rays, γ-rays [21, 22], or fast ions [23], GdBNs 
significantly amplify radiation-induced cell killing, even 
in the case of U87 glioblastoma cells derived from a 
highly aggressive and radio-resistant human tumor [24, 
25]. Concomitantly, GdBNs can serve as good contrast 
agents [19, 26] while they are rapidly eliminated from the 
organism by the kidneys, with no evidence of toxicity [24, 
27–30].
GdBNs exert strong radiosensitizing effect on tumors 
[22–24, 31–33] when combined with several types of 
radiation of different energies (≥keV). For γ-rays used 
in this work, the radiosensitization appears due to 
prominent physical processes, namely the photoelec-
tric and Compton effects, in dependence of the photon 
beam energy. The cascade of GdBNs-mediated processes 
resulting to cell radiosensitization starts with electron 
‘showers’ emitted from nanoparticles upon irradia-
tion and continues with water radiolysis producing free 
reactive oxygen species (ROS) [34, 35]. As these ROS 
are concentrated in nano-clusters, they induce complex 
nanosized bio-damages that are lethal for the cells [36, 
37]. NPs thus increase the ionizing density (and dam-
age) at the nanoscale, without influencing the macro-
scopic dose deposition [36, 38–40]. In accordance with 
this hypothesis, Burger and co-workers [41] showed that 
a high focal concentration of NPs is required to ensure 
an increased cellular inactivation by irradiated NPs. Also 
the local effect model (LEM) simulations suggested that 
the nanosized character of dose amplification is the key 
aspect of the ‘nanosensitization’ [38, 39].
Though the radio-enhancing effect of GdBNs has been 
clearly proved and explained in terms of physics, the 
structures and processes targeted by these (and other) 
nanoparticles in cells remain a subject to controversy. 
The nuclear DNA is logically the first suspect: it repre-
sents a critical cell structure and its damage by double 
strand breaks (DSBs) is commonly considered as the 
cause of radiation-induced cell death [42, 43]. Hence, it 
has been proposed that nanoparticles radiosensitize cells 
through amplifying the DSBs damage. However, several 
in vitro studies demonstrated [12, 13, 23, 32, 44, 45] that 
the radiosensitizers (metal complexes or NPs) are located 
in the cell cytoplasm. Stated in other words, NPs seem to 
amplify cell killing without entering the nucleus. As dis-
cussed below, these results open the question of whether 
secondary electrons only produced in close vicinity of 
cytoplasmically localized NPs may reach and damage to a 
sufficient extent the cell nucleus or whether cytoplasmic 
structures in closer proximity to NPs represent another 
(or even a more important) target for NPs-mediated 
radiosensitization.
Jones et al. [46] showed that also the dose enhancement 
mediated by NPs can spread as far as several microme-
ters. Leung et  al. [47] reported that electrons can travel 
up to 3 μm or even 1 mm when activated by a 50 kVp and 
6  MV source, respectively; this flying range is sufficient 
to reach the nuclear DNA. Thus, at least some electrons 
from NP-mediated electron showers might directly dam-
age the nuclear DNA [41]. Whether this is sufficient to 
enhance cell killing remains a question.
Important evidence that the cytoplasmic damage may 
strongly influence the cell nucleus emerged from recent 
microbeam experiments. The group of Kevin Prise dem-
onstrated that also cytoplasmically micro-irradiated 
cells develop 53BP1 protein foci—the markers of DNA 
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DSBs—dispersed in the nucleus [48]. Moreover, these 
experiments revealed that the radiation damage to the 
cytoplasm can elicit 53BP1 foci formation both in directly 
exposed and bystander cells, independently of the dose 
and number of cells targeted. Hence, we can conclude 
that the cytoplasmic injury might also be followed by 
DNA damage with a corresponding biological response, 
though its kinetics for the pan-cellular and cytoplasmic 
irradiations differs.
The expansion of radiation damage from the cytoplasm 
to the nucleus is thus probably mediated by ROS [49]. In 
accordance, we can hypothesize that NPs might enhance 
the nuclear DNA damage by amplifying ROS production 
in the cytoplasm. In addition, disruption to protein trans-
port and synthesis in the cytoplasm upon high radiation 
doses may slow down or even preclude DNA repair and 
further contribute to the cell killing by irradiated NPs. 
However, the information on the damage exerted by NPs 
to the nuclear DNA remains very limited and conflicting 
as available studies feature huge heterogeneity precluding 
the combination of results. This situation calls for further 
comprehensive analyses comparing the impact of phys-
ico-biological properties of various NPs and different 
treatment protocols on the radiosensitization processes.
In this work, together with providing a detailed infor-
mation on the intracellular localization of GdBNs, we 
evaluated by currently the most sensitive method to 
detect DSBs how these nanoparticles influence the radia-
tion damage introduced to the genomic DNA and how 
these lesions are consequently repaired during a long 
period of time post-irradiation (PI) in radioresistant U87 
human glioblastoma cells. Our results represent new, 
direct and surprising evidence on the radiosensitizing 
mechanism of GdBNs: We demonstrate that this mecha-
nism does not rely on the amplification of DSBs damage 
in the genomic DNA. Rather, based on our previous find-
ings, we suppose that injury to the endosomes and lys-
osomes play a crucial role. These results may change the 
current dogma suspecting the nuclear DNA and/or mito-
chondria as the key targets for the nanoparticle-mediated 
radiosensitization.
Methods
Gadolinium-based nanoparticles (GdBNs) were syn-
thesised by the group of O. Tillement (LPCML, Lyon, 
France). Briefly, the GdBN consist of a polysiloxane core 
surrounded by gadolinium chelates covalently grafted 
on the inorganic matrix. The procedure of synthesis is 
detailed in Morlieras et  al. [50] and Mignot et  al. [27]. 
Briefly, the diameter of GdBNs was 3.0  ±  1.0  nm and 
their molecular mass 8.5  ±  1  kDa. These nanoparti-
cles are stable, so they can be lyophilized and stored at 
4  °C. For the analysis of DNA DSBs, label-free GdBNs 
were used. For the localization experiments by confo-
cal microscopy, GdBNs were fluorescently labeled with 
Cyanine 5.5 (GdBNs-Cy5.5) as described elsewhere [50]. 
We have demonstrated earlier, by using different micros-
copy techniques [including synchrotron radiation deep 
ultraviolet microscopy (SR-DUV), transmission electron 
microscopy, and confocal microscopy], that labeling of 
GdBNs with cyanine 5.5 does not influence the nanopar-
ticle localization [31].
Cell culture
U87 cells grew (37  °C, 5 % CO2) in Dulbecco’s modified 
essential medium (Life Technologies) supplemented with 
10  % heat-inactivated fetal calf serum (PAA), 100  U/ml 
penicillin (PAA), 100 μg/ml streptomycin (PAA), and 1 % 
NEAA (Life Technologies).
Cell irradiation with γ‑rays
U87 cells grown on microscopic slides (for DNA dam-
age detection experiment) or in culture flasks (for the 
clonogenic survival experiment) were irradiated in cul-
ture medium at room temperature (RT) with 1 or 4  Gy 
of γ-rays (1  Gy/min), delivered by a 60Co irradiator 
(Chisostat, Chirana). During irradiation, the samples 
were kept in thermo-isolating boxes to prevent sample 
infection and temperature changes, and then immedi-
ately returned to the incubator (37 °C, 5 % CO2).
Quantification of GdBN‑mediated cell radiosensitization 
by clonogenic assay
Part of U87 cells followed incubation with 1 mM GdBNs 
for 1  h and consequently some samples were irradiated 
with 1 or 4 Gy of γ-rays as described above. The survival 
of cells was quantified by clonogenic assay and compared 
for non-irradiated and irradiated cells, in both cases 
either incubated or not incubated with GdBNs. After 
irradiation, cells were trypsinized and plated into 60 mm 
Petri dishes (Falcon 3002) at a density of 100 surviv-
ing cells per dish. The plating efficiency was 13 %. After 
14 days of incubation, the colonies were fixed with 50 % 
methanol and stained with 1 % methylene blue. The colo-
nies were counted manually by an experience examiner 
to determine the cell surviving fractions.
Confocal microscopy studies of GdBNs localization
U87 cells were incubated with GdBNs labeled with 
Cy5.5 (GdBNs-Cy5.5) (1 mM) for 1, 6, and 16 h, respec-
tively. Afterward, the cells were rinsed three times with 
1×  PBS and maintained in HBSS medium during the 
time of observation. The localization of GdBNs by con-
focal microscopy was performed with a LEICA SP5 
confocal system, under constant temperature and CO2 
levels (37 °C and 5 % CO2), at the Centre de Photonique 
Page 4 of 15Štefančíková et al. J Nanobiotechnol  (2016) 14:63 
Bio-Medical (CPBM), University Paris Sud, Orsay, 
France. GdBNs-Cy5.5 fluorescence was excited at 633 nm 
and the emission was detected in the 650–750 nm range. 
Images were recorded for three different z-positions 
(0.2 μm-thick confocal slices) for each cell. Transmission 
imaging was performed to visualize the size and shape 
of the cells and to discriminate between the nucleus and 
the cytoplasm. The fluorescence images obtained were 
merged with the transmission images by ImageJ soft-
ware (Rasband, W.S., ImageJ, U. S. National Institutes of 
Health, Bethesda, Maryland, USA, http://www.imagej.
nih.gov/ij/, 1997–2011) to determine the intracellular 
localization of GdBNs-Cy5.5. The same settings were 
used to perform fluorescence spectroscopy. The spectra 
for different cell compartments were registered together 
with random background (out-of-cell) values.
Immunostaining of nuclear DSBs and their visualization 
by confocal microscopy
DSBs were detected in spatially (3D) fixed cells using a 
high-resolution confocal microscopy; the procedure was 
optimized by Falk et al. [51]. To maximize the sensitivity 
and fidelity of DSBs analyses, we took advantage of a dual 
fluorescence immunostaining to simultaneously visualize 
γH2AX and 53BP1 repair foci, the independent markers 
of nuclear DSBs [52, 53].
U87 cells were incubated with 1 mM GdBNs for 1, 6, and 
24 h, respectively, and consequently some samples were irra-
diated with 1 or 4 Gy of γ-rays (1 Gy/min) as described. At 
the times post-irradiation (PI) of 5, 15, 30 min, 1, 2, 4, 8, and 
24 h, the cells were spatially (3D) fixed with 4 % formaldehyde 
in 1X PBS for 10 min/RT, washed 3 times for 5 min each in 
1X  PBS, permeabilized with 0.2  % Triton X 100/PBS for 
15  min/RT, and again washed 3  times  for 5  min each in 
1X  PBS. Before the incubation with the primary antibod-
ies (10 min RT and then overnight at 4  °C), the cells were 
blocked with 7 % inactivated fetal bovine serum +2 % bovine 
serum albumin/PBS for 30 min at RT.
Antibodies from two different hosts were used to 
simultaneously detect two DSBs markers in the same 
nuclei: anti-phospho-H2AX (serine 139) (mouse, mono-
clonal, dilution 1:500, Upstate Biotechnology) and anti-
53BP1 (rabbit, polyclonal, dilution 1:500, Cell Signalling). 
Secondary antibodies, affinity purified FITC-conjugated 
donkey anti-mouse (diluted 1:200) and Cy3-conjugated 
donkey anti-rabbit (diluted 1:100) (both from Jackson 
Laboratory), were applied for 1 h in the dark at RT after 
the pre-incubation of slides with 5.5  % donkey serum/
PBS for 30  min at RT. After washing 3  times  for 5  min 
each in 1X  PBS, cells were counterstained with 1  μM 
TOPRO-3 (Molecular Probes) in saline sodium citrate 
(2×  SSC). Vectashield medium (Vector Laboratories) 
was used for the final mounting of slides.
Forty z-stacks, acquired at 0.2 μm steps, were recorded 
(at IBP ASCR Brno, CR) in three separate spectral 
channels by the confocal microscope Leica SP5 (Leica 
Microsystems) and an automated Leica DM RXA fluo-
rescence microscope equipped with a Nipkow disk 
(Jokogawa, Japan) for confocal imaging (in detail 
described in Kozubek et  al. [54, 55]). The visualization 
and analysis of the 3D images were performed using 
the Aquarium software [56], 3D image viewer [56], and 
ImageJ software (Rasband, W.S., ImageJ, U. S. National 
Institutes of Health, Bethesda, MD, USA, http://www.
imagej.nih.gov/ij/, 1997–2011). Fifty to 100 cells were 
analyzed for each treatment and period of time PI. This 
approach allowed us to analyze (a) the initial induction 
of DSBs immediately after the irradiation (5 min PI), (b) 
the repair kinetics of these lesions during a long period of 
time post-irradiation (up to 24 h), and (c) the persistence 
of unrepaired DSBs at late times PI (8 and 24 h). The rep-
resentative maximum images composed of 40 confocal 
0.2 µm thick slices are shown in Figs. 3, 4, 5 and 6.
Data analysis
The SigmaPlot 12.5 (Systat Software Inc.) has been used 
for data analysis. The Mann–Whitney Rank Sum Test 
was employed to compare at all the particular periods of 
time PI the distributions of DSBs (γH2AX/53BP1 foci) 
numbers per nucleus in untreated control cells and cells 
incubated with 1 mM GdBNs for 1 h. The relevant P val-
ues are indicated in Tables  1 and 2. Around 100 nuclei 
were quantified in each single experiment. To mutually 
compare the distributions of DSBs for untreated con-
trols and cells incubated with GdBNs for 1, 6, and 24 h, 
respectively, the Kruskal–Wallis One Way Analysis of 
Variance on Ranks (a non-parametric equivalent of the 
one-way analysis of variance, ANOVA) was applied; the 
corresponding P values are shown in Table 3.
In Figs. 3, 4 and 5, the data are displayed in the form 
of box graphs showing the distributions of DSBs foci per 
nucleus. The boxes include 50  % of the values (25th to 
75th percentile) centred on the median (the horizontal 
line through the box). The mean values are represented 
by the squares within the boxes. The vertical lines begin 
at the 5th percentile and end at the 95th percentile. Rep-
resentative nuclei for each time point PI are shown above 
the respective box.
Results
Uptake and localization of GdBNs in U87 cells
First, we analyzed by confocal microscopy the cellular 
uptake and localization of 1  mM GdBNs in U87 cells 
during 16 h-long period of observation. Figure 1a shows 
exclusively cytoplasmic localization of GdBNs (labelled 
with Cy5.5) as demonstrated by ‘correlative’ transmission 
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light images and confocal fluorescence images. To further 
probe the intracellular distribution of GdBNs, we com-
pleted confocal microscopy by fluorescence spectroscopy 
(Fig.  1b) of the regions of interest located in (a) the 
nucleus, (b) the cytoplasm, and (c) the extracellular space 
(plain medium). The spectra measured in the cytoplasm 
displayed an intensive peak at λ =  688  nm, which cor-
responds to the fluorescence of GdBNs labelled with 
Cyanine 5.5. This peak was clearly absent in the spectra 
obtained inside the nucleus or outside the cells. Both 
microscopy and spectrometry thus confirmed absence of 
GdBNs in the cell nucleus.
Next, we compared the uptake and localization of 
GdBNs in U87 cells also for two shorter incubation peri-
ods: 1 and 6 h. As demonstrated by Fig. 2, GdBNs were 
already internalized after 1  h incubation and longer 
incubation times of 6 and 16  h (see also Fig.  1) had no 
influence on GdBNs uptake efficacy. For all the periods 
of time studied, GdBNs were localized in the cytoplasm 
of U87 cells without penetrating into the nucleus. In con-
trast to the situation described for SQ20B cells by Miladi 
and coworkers [33], we observed no clustering of NPs on 
the cytoplasmic membrane.
Effect of GdBNs on nuclear DNA damage in U87 cells
We investigated whether GdBNs alone or in combination 
with irradiation cause the nuclear DNA damage and/or 
Table 1 Effect of GdBNs on DSBs quantity in irradiated (1 Gy) U87 cells
NI 5 min 15 min 30 min 1 h 2 h 4 h 8 h
U87 1.4 18.1 21.1 19.7 14.9 8.7 5.5 3.1
U87 + GdBNs 1.2 16.7 19.3 17.5 15.7 8.6 5.0 2.9
P 0.533 0.111 0.083 0.096 0.379 0.970 0.485 0.241
Table 2 Effect of  GdBNs on  DSBs quantity in  irradiated 
(4 Gy) U87 cells
NI 1 h 4 h 8 h 24 h
U87 1.9 42.4 20.6 12.2 5.0
U87 + GdBNs 2.0 42.9 20.1 12.3 4.9
P 0.059 0.731 0.916 0.350 0.686
Table 3 Effect of  incubation times  with GdBNs on  DSBs 
quantity in irradiated (1 Gy) U87 cells
NI 5 min 1 h 4 h 24 h
U87 1.6 12.7 12.3 4.9 2.2
U87 + GdBNs 1 h 1.6 14.4 12.7 5.8
U87 + GdBNs 6 h 1.5 11.3 12.5 5.1 1.8
U87 + GdBNs 24 h 12.3 11.9 6.0 2.0
P 0.433 0.091 0.647 0.328 0.699
Fig. 1 Localization of GdBNs-Cy5.5 nanoparticles in U87 cell. a Correlative fluorescence confocal image and transmission light image of U87 cell 
with internalized GdBNs-Cy5.5 (red) at the end of 16 h-long observation. The scale bar equals to 10 µm. The circles represent the regions of fluores-
cence spectroscopy measurements, cytoplasm (blue), nucleus (red), and plain medium (green). b Fluorescence emission spectra of the three regions
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influence repair of these lesions. We focused on the DNA 
double strand breaks (DSBs; visualized as γH2AX foci 
co-localizing with 53BP1 foci) that represent the most 
important type of DNA damage.
Effect of GdBNs on nuclear DNA in non‑irradiated cells 
(nanoparticle genotoxicity)
Biological toxicity of nanoparticles represents a criti-
cal issue in therapy. We demonstrated earlier [31] that 
GdBNs used in this study are not toxic and neither 
the survival nor the division of cells. However, several 
authors reported that the silver [57–59] and gold nano-
particles enhance the levels of γH2AX [60] and the oxida-
tive stress [61], both in normal and cancer cells. Hence, 
we further investigated the effect of our GdBNs on the 
DNA integrity in U87 cells without irradiation.
Figure  3 compares the distribution of γH2AX/53BP1 
(DSBs) foci numbers in U87 cells never incubated with 
GdBNs (control cells) and incubated with 1 mM GdBNs 
for 1 and 6 h, respectively. For both the periods of time, 
without irradiation, the cell treatment with GdBNs had 
no effect on the number of DSBs detected. The aver-
age values from two independent experiments were 1.6 
DSBs/nucleus for untreated cells, 1.5 DSBs/nucleus 
for cells incubated with GdBNs for 1  h, and 1.6 DSBs/
nucleus for cells incubated with GdBNs for 6  h. Hence, 
GdBNs of parameters used in this work are not genotoxic 
by themselves.
Effect of GdBNs on nuclear DNA DSBs induction and repair 
in irradiated U87 cells
In the next step, we studied how cytoplasmic GdBNs 
influence the extent and reparability of DSBs intro-
duced to the nuclear DNA by irradiation with two 
different doses of γ-rays, 1 and 4  Gy, respectively. The 
application of high resolution confocal immuno-fluo-
rescence microscopy with two independent DSBs mark-
ers (γH2AX and 53BP1) allowed us to precisely analyze 
the extent of DSBs induction in intact cells as early as 
5  min post-irradiation (PI). Consequently, we evaluated 
the repair of DSBs in terns of γH2AX/53BP1 foci disap-
pearance over 8 h-long period of time PI; this period is 
sufficient to repair the majority of DSBs and allows con-
sidering effects of the two main DSBs repair pathways, 
Fig. 2 Localization of GdBNs-Cy5.5 nanoparticles in U87 cells as a function of the incubation time. Correlative fluorescence confocal images and 
transmission light images of U87 cells incubated with 1 mM GdBNs-Cy5.5 (red) for three different incubation times: a—1 h, b—6 h and c—16 h. 
Scale bars equal to 10 µm
Fig. 3 Effect of GdBNs on DSBs formation in non-irradiated U87 cells. 
Distribution of DSBs foci numbers are compared for non-irradiated 
U87 cells never incubated with GdBNs (black) and incubated with 
1 mM GdBNs for 1 h (purple) and 6 h (blue). The respective cell nuclei 
are shown as the maximum images (composed of 40 confocal slices 
0.2 μm-thick) with 3D projections; γH2AX—green, 53BP1—red, chro-
matin—artificially blue
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NHEJ—non-homologous end-joining, and HR—homolo-
gous recombination. To follow both the kinetics and the 
final efficiency of DSBs repair, we scored γH2AX/53BP1 
foci in 7 time points PI. The results for U87 cells irradi-
ated with 1 Gy of γ-rays and incubated or not incubated 
with 1 mM GdBNs for 1 h are summarized in Fig. 4 and 
Table 1.
Average numbers of DSBs foci per nucleus at indi-
cated periods of time PI are compared for U87 cells 
irradiated with 1 Gy of γ-rays in absence or presence of 
1  mM GdBNs (1  h incubation). Non-irradiated control 
cells (NI) are included. P values indicate the significance 
of differences between cells untreated and treated with 
GdBNs, respectively.
For all the periods of time PI, we observed compara-
ble mean/median numbers of γH2AX/53BP1 foci per 
nucleus between the U87 cells incubated with GdBNs 
and the untreated controls. These results show that both 
the extent of DSBs induction measured at 5 min PI and 
the kinetics of DSBs repair between 5 min PI and 8 h PI 
are not affected by GdBNs present in the cytoplasm of 
irradiated U87 cells.
To check whether these conclusions hold also for higher 
radiation doses, we repeated the above described experi-
ments also with 4 Gy irradiation. This dose also ensures 
more extensive DNA damage which in turn allows recog-
nition of smaller differences between the compared sam-
ples. U87 cells were again incubated with 1 mM GdBNs 
for 1 h; however, this time we have focused on less time-
points (1, 4, 8 and 24 h) but dispersed along a period of 
time extended up to 24 h PI. Indicated time-points were 
selected as they allowed us to estimate: (1) the extent of 
DSBs induction (since the numbers of γH2AX/53BP1 
foci at 1  h PI still approach the maximum values), (2) 
the efficiency of NHEJ and HR repair pathways (4/8  h 
PI, respectively), and (3) also the extent of DSBs that are 
repaired only with difficulty (and persist in nuclei 24 h PI, 
when the repair process are usually accomplished even 
for 4 Gy and higher dose γ-irradiations). The results are 
summarized in Fig. 5 and Table 2. As for 1 Gy, we found 
only insignificant differences between the mean/median 
γH2AX/53BP1 (DSBs) foci numbers in cells incubated or 
not incubated with GdBNs.
Altogether, these results indicate that our GdBNs 
(1  mM)—alone or in combination with irradiation—do 
not affect nuclear DNA. GdBNs of defined parameters 
influenced neither the induction of DSBs nor the kinetics 
and efficiency of their repair. Based on these results, we 
conclude that GdBNs may amplify radiation-induced cell 
killing through effects independent on the nuclear DNA.
Average numbers of DSBs foci per nucleus at different 
periods of time PI are compared for U87 cells irradiated 
with 4  Gy of γ-rays in absence or presence of 1  mM 
GdBNs (1  h incubation). Non-irradiated control cells 
(NI) are also included. P values indicate the significance 
of differences between cells treated and untreated with 
GdBNs.
Influence of the incubation time with GdBNs on DSBs foci 
induction by γ‑rays and their repair
As reviewed in Sancey et  al. [24], available studies on 
GdBNs used different nanoparticle incubation times. At 
the same time, several reports with gold [62] and gado-
linium [32] NPs demonstrated that this experimental 
parameter has a significant effect on NPs concentration 
and distribution in the cells. This makes comparisons and 
interpretations of results problematic. Thus, we investi-
gated how different times of incubation with our GdBNs 
influence the induction of DSBs by γ-rays and repair of 
these lesions.
As in the previous experiments, we quantified 
γH2AX/53BP1 (DSBs) foci in U87 cells incubated with 
1 mM GdBNs and exposed to 1 Gy of γ-rays. The results 
for 0, 1, 6, or 24  h-long incubations followed by DSBs 
quantification at 5 min, 1, 4, and 24 h PI, respectively, are 
presented in Fig. 6 and Table 3. Evidently, the prolonged 
incubations increased neither the induction of DSBs 
lesions nor delayed their repair. These results thus agree 
with our observation presented in Fig. 2 that GdBNs do 
not penetrate in the nucleus even at longer incubation 
times.
Average numbers of DSBs foci per nucleus in different 
periods of time PI are compared for U87 cells irradiated 
with 1  Gy of γ-rays in absence or presence of GdBNs, 
applied for 1, 6 or 24 h prior to irradiation. Non-irradi-
ated control cells (NI) are also included. P values indicate 
the significance of differences between samples for each 
period of time PI.
Radiosensitizing effect exerted by irradiated GdBNs
Recently, we have shown that GdBNs of the parameters 
and concentration used in this work (1 mM) exert a sub-
stantial radiosensitizing effect in CHO cells irradiated 
with He2+ or C6+ high energy ions [23]. In our previ-
ous work, we have also confirmed the radiosensitizing 
effect of these GdBNs in U87 cells irradiated with γ-rays 
[31]. However, a controversy exists in the literature on 
the radiosensitizing efficiency of higher (about  >1  mM) 
GdBN concentrations. Hence, we confirmed here by 
clonogenic assay the effects of 1 mM GdBNs on the cell 
vitality and proliferation potential. Figure  7 shows sig-
nificantly lower clonogenic survival of U87 cells in pres-
ence of GdBNs at doses 1 and 4  Gy, respectively; the 
non-irradiated controls are also included. Though the 
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Fig. 4 Effect of GdBNs on DSBs formation and repair in irradiated (1 Gy) U87 cells. Distribution of DSBs foci numbers are compared for irradiated 
U87 cells a never incubated with GdBNs and b incubated with 1 mM GdBNs for 1 h. Non-irradiated controls are indicated as NI. The respective maxi-
mum images of representative nuclei for each period of time PI are shown above: γH2AX—green, 53BP1—red, chromatin—artificially blue
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NP-mediated radiosensitization is less prominent at 
4 Gy as compared with 1 Gy dose (see Discussion), these 
results unequivocally confirm the presence of the radio-
sensitizing effect upon the conditions used in this work. 
Therefore, missing effects of GdBNs on nuclear DNA 
damage and repair support the idea of cell radiosensitiza-
tion by GdBNs that originates in the cytoplasm, instead 
of reflecting the absence of the radiosensitizing effect.
Discussion
To our best knowledge, there are only few other reports 
on the effects of nanoparticles on DSBs formation and/
or repair upon irradiation. In this work, we show that 
nanoparticles irradiated in the cytoplasm can potentiate 
radiation-induced cell killing without a need to penetrate 
into the cell nucleus and damage DNA. This conclusion 
might be surprising concerning the fact that the nuclear 
DNA is undoubtedly the most important and, at the same 
time, fragile structure in the cell. For a long time, a direct 
damage to DNA has been assumed as the key event start-
ing the cascade of reactions mediating the cell response 
to irradiation [63]. However, microbeam irradiations only 
restricted to specific cellular subcompartments [49, 63, 
64] clearly demonstrated that DNA can be damaged even 
without being directly hit; the cytoplasmic and also the 
extracellular irradiation triggered similar DNA damage 
and associated important cellular pathways as the dose 
deposited in the nucleus [65–67]. Moreover, several stud-
ies suggested that damage to the mitochondria or cell 
membrane markedly contribute to the cytotoxic effect 
of radiations [68]. Therefore, the whole cell, rather than 
DNA only, should be considered a sensor of radiation 
exposure [64].
The only cytoplasmic organelles containing DNA in 
human cells are the mitochondria. As the ‘energy gen-
erators’, the mitochondria are vital for the cell. However, 
our previous colocalization studies [31] excluded the 
possibility that GdBNs localize into (or close to) these 
organelles. On the other hand, we have revealed that 
GdBNs of parameters used in this work colocalize with 
the lysosomes in U87 cells [31]. In the light of our fur-
ther findings presented here, i.e. that NPs affect neither 
the damage nor the repair of the nuclear DNA, we pro-
pose a provoking hypothesis that the radiosensitization 
mediated by our GdBNs is triggered by damage to the 
lysosomes and endosomes and potentially other cyto-
plasmic organelles in their proximity.
Several reports [69–72] revealed only recently that 
the lysosomes, these still mysterious organelles, play an 
important role in the initiation of the cell death signalling 
(reviewed e.g. in [72, 73]), regulation of the cell cycle [73] 
and energy metabolism (reviewed e.g. in [74]). Already a 
moderate lysosomal rupture forces the cell to apoptosis 
while more pronounced lysosomal leak results in necro-
sis without caspases activation [72, 73, 75]. Though we 
currently run experiments on this topic, we cannot pro-
vide a direct evidence for the lysosome damage mediated 
by our GdBNs (since these NPs are no more available). 
Nevertheless, Heid et al. [76] recently demonstrated that 
release of mitochondrial ROS subsequently leads to the 
Fig. 5 Effect of GdBNs on DSBs formation and repair in irradiated 
(4 Gy) U87 cells. Distribution of DSBs foci in U87 cells never incubated 
with GdBNs (a) and incubated with 1 mM GdBNs for 1 h (b). Non-
irradiated controls (NI) are also compared. The respective maximum 
images of representative nuclei for each period of time PI are shown 
above: γH2AX—green, 53BP1—red, chromatin—artificially blue
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lysosomal membrane permeabilization (LMP). Hence, 
we can legitimately suppose that huge amounts of ROS 
produced by irradiated NPs in the lysosomes can easily 
disintegrate the membranes in their substantial fraction, 
with the already described consequences for the cell.
In accordance with fundamental changes in the long-
accepted paradigm on the role of the cytoplasm in the 
cell response to radiation, our results seem to disclose 
new important features of the mechanism by which 
GdBNs exert their radiosensitizing effect; however, the 
details and complexity of NPs-mediated cellular radio-
sensitization still remain a mystery. We speculate here 
about new molecular targets for NPs, other than the 
nuclear or mitochondrial DNA; this offers a broad scale 
of new opportunities for much safer therapeutic attacks 
on cancer cells. Indeed, many survival attributes of neo-
plastic cells are determined by extra-nuclear structures 
and processes, including mitochondrial and lysosomal 
proteins involved in (anti)apoptotic, cell cycle, and cell 
damage signaling pathways.
Fig. 6 Effect of incubation times with GdBNs on DSBs formation and repair in irradiated U87 cells. Distributions of DSBs foci numbers are compared 
for U87 cells irradiated with 1 Gy of γ-rays and never incubated with GdBNs (a) or incubated with 1 mM GdBNs for 1 h (b), 6 h (c) and 24 h (d). Non-
irradiated controls (NI) are also compared. The respective maximum images of representative nuclei are shown above: γH2AX—green, 53BP1—red, 
chromatin—blue
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Our preliminary experiments (results not shown) with 
other cell types and nanoparticle types of the similar 
size as GdBNs used in this work suggest that the conclu-
sions (the cytoplasm damage-based radiosensitization, 
no escalation of DNA damage and no DNA repair inhi-
bition), postulated in the above paragraphs for U87 cells 
and GdBNs, could be more generally valid.
As discussed later in more detail, many key factors may 
determine intracellular localization and distribution of 
NPs and, in turn, the extent and the mechanism of radi-
osensitization. It is, for instance, the size of NPs, which 
also dictates the effectivity of NPs intake and exclusion 
by the cells (e.g. Moser et  al. [77]). The NPs concentra-
tion and composition as well have been reported to influ-
ence distribution of NPs in cells [32, 33] with a significant 
impact on the radiosensitization intensity and, perhaps, 
its mechanism (see later). Finally, as also demonstrated 
by our results, the radiation dose seems to be unimpor-
tant concerning the mechanism of NP-mediated cell 
radiosensitization (physical processes of NPs activation 
and damage introduction to biomolecules are still the 
same) but the contribution of NP-mediated effects to cell 
killing by irradiation depends on the dose (see Fig. 7). As 
soon as the radiation dose is high enough to activate NPs 
to an extent sufficient for damaging cytoplasmic orga-
nelles (lysosomes or other) in NPs proximity, additional 
dose escalation could not be expected to further increase 
the radiosensitization (while radiation damage to DNA 
still grows with the dose). Hence, for higher doses, the 
additional value of radiosensitization to therapy relatively 
decreases (see Fig. 7). These results may also explain why 
some authors, working with higher radiation doses, did 
not observed radiosensitizing effect of 1  mM GdBNs 
[22]. To conclude, our results are not limited to the cell 
type, nanoparticle type and conditions used herein; how-
ever, they should be generalized only with caution since 
our understanding to biological processes that take place 
in cells after the cytoplasmic irradiation, especially if NPs 
are present, is still very limited. Systematic studies in liv-
ing cells are also necessary to understand how the key 
physical and biological factors mutually interact in pro-
viding the final radiosensitizing effect.
In addition to the efficiency, the genotoxicity of NPs 
represents another crucial issue in the context of therapy. 
It has been already demonstrated for cells loaded with sil-
ver NPs [58, 59] that even cytoplasmically localized NPs 
can induce DSBs without being irradiated. Preferentially 
sequestered in tumors though, NPs thus seem to unde-
sirably damage also normal cells. By contrast, we showed 
here by currently the most sensitive method to detect 
DSBs that GdBNs of our parameters and under condi-
tions used in this work are not genotoxic. This points 
to the importance of careful studies on the genotoxicity 
of each particular NPs type. Taken together, our results 
open new optimistic horizons for further development of 
efficient but safe NPs-based therapies of malignant and 
also non-malignant diseases; however each individual 
NPs type should be carefully characterized before being 
used in clinical practice, both in terms of its physical 
properties and biological activity.
There are only few studies our results can be compared 
with. In agreement with the present work, Jain et al. [2] 
demonstrated that 1.9  nm gold NPs neither enhance 
radiation-induced DSBs formation nor inhibit DNA 
repair in MDA-MB-231 breast cancer cells irradiated 
with MV electrons. On the other hand, Chithrani et  al. 
[3] observed an increase of DSBs induction in HeLa cells 
incubated with 50 nm citrate-coated gold NPs irradiated 
with 6 MV photons. Similarly, Berbeco and co-work-
ers [78] described a significant increase in DNA dam-
age for 50 nm gold NPs in HeLa cells when activated by 
clinical MV photon beams. Finally, Zhu and co-workers 
[79] showed augmentation of DNA damage for mega-
voltage X-rays (6  MeV) and gold NPs in the size range 
of 20–74  nm (HepG2 cells). Taken together, it seems 
that bigger gold NPs enhance the DNA damage while 
the smaller NPs do not. Contradictory effects of NPs on 
DNA might be thus, at least partially, explained by their 
size. Indeed, for physical reasons, nanoparticles of 50 nm 
in diameter provide stronger radioenhancing effect than 
their smaller variants [3, 41]. However, Mowat et  al. 
[22] and Miladi et al. [33] evidenced a significant rise in 
the nuclear DNA damage when they irradiated U87 or 
SQ20B cells in presence of GdBNs as small as 3 nm.
In the context of present article, Mowat’s work [22] is 
particularly interesting since the authors used similar 
Fig. 7 Effect of GdBNs on clonogenic survival fraction of U87 cells. 
Surviving fractions of U87 cells never incubated with GdBNs (grey) or 
in the U87 incubated with 1 mM GdBNs for 1 h (purple) and irradiated 
by 1 and 4 Gy of γ-rays (60Co), respectively. Non-irradiated controls 
(dose 0) were normalized to 1
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experimental design (U87 cells, gadolinium-based NPs, 
and γ-ray irradiation) but came to different conclusions. 
The difference between our results and those of Mowat 
and coauthors [22] might reflect several factual and/or 
experimental factors:
1. Nanoparticles design: The design of GdBNs used in 
the present and Mowat’s work [22] is different. We 
cannot exclude that differently designed NPs (gado-
linium oxide core surrounded by polysiloxane shell 
vs. polysiloxane core surrounded by gadolinium 
chelates covalently grafted on the inorganic matrix), 
though composed of the same material, behave dif-
ferently in cells and increase cell killing by various 
biological mechanisms.
2. Nanoparticles concentration and intracellular locali-
zation: Rima et al. [32] revealed by transmission elec-
tron microscopy that the number per cell of vacuoles 
containing GdBNs as well as the average size of these 
vacuoles increase with GdBNs concentration up to 
0.6 mM; however, for concentrations up to 2 mM the 
average vacuole size still increases but their number 
per cell decreases. Confirming a functional impor-
tance of these findings, another work demonstrated 
that the size of NPs clusters is more relevant param-
eter determining the radiosensitizing effect of NPs 
than their intracellular concentration as the whole 
[32]. The concentration effects were also mentioned 
in a recent article of Miladi et al. [33] where GdBNs 
(labelled with Cy5.5) started to cluster on the mem-
brane of SQ20B cells when higher (≥0.8  mM) NP 
concentrations were used. By contrast, with 1  mM 
GdBNs, we observed an intensive nanoparticle 
uptake by U87 cells without any signs of their accu-
mulation on the membrane. This strictly cytoplasmic 
residence of 1 mM GdBNs agrees with our previous 
results in CHO cells [23] obtained with NPs of the 
same parameters.
 Along with influencing the NPs intracellular distri-
bution, the concentration of NPs seems to affect the 
mechanism of radiosensitization and the final radio-
sensitizing effect. The experiments have been per-
formed particularly using low gadolinium concentra-
tions ranging from 0.1 to 1 mM (see Table 3 in the 
review paper [24]). In two different cancer cell lines, 
U87 (glioblastoma cell line) and SQ20B (squamous 
cell carcinoma cell line), the moderate gadolinium 
concentrations (0.4–0.7 mM) potentiated the effects 
of radiation most efficiently in in  vitro conditions 
[22, 28]. Mowat and co-workers [22] showed that 
while 0.5  mM GdBNs substantially enhance radia-
tion-induced DSBs foci formation as quantified by 
comet assay, this effect is absent or only minor for 
higher (1 and 2 mM) GdBNs concentrations. In other 
studies [22, 29], enhanced DNA damage as moni-
tored by γH2AX levels appeared for the concentra-
tions between 0.4 and 0.6 mM but not for the con-
centration of 2 mM [22]. In accordance, Rima et  al. 
[32] found that the quantity of gadolinium in U87 
cells and SQ20B cells increases almost linearly with 
the GdBNs concentration but the cell killing by irra-
diation peaks at the concentration of 0.6  mM and 
almost disappears at 1 mM. In contrary to the above 
mentioned studies, Porcel et  al. [23] demonstrated 
significant radiosensitization of CHO cells exposed 
to He2+ and C6+ high energy ions, respectively, in 
presence of 1  mM GdBNs of the same parameters 
as used in the present work. The extent of U87 cell 
radiosensitization by 1 mM GdBNs after irradiation 
with 1 or 4 Gy of gamma rays is quantified in Fig. 7 
and is obvious. Even small differences in the GdBNs 
concentration (in combination with other factors) 
may thus dramatically change the radiosensitizing 
effect; the concentrations around 1 mM seem to be 
most controversial in this respect. Hence, by choos-
ing 1  mM GdBNs, we aimed to complete the men-
tioned studies and make another step towards our 
better understanding of the radiosensitization medi-
ated by these NPs.
3. Nanoparticle surface modifications and labeling: 
Mowat et al. [22] used GdBNs conjugated with FITC 
for their DSBs studies. While we have proved consist-
ently that the intracellular behavior of free GdBNs and 
GdBNs labeled with Cy5.5 does not differ [31], it is pos-
sible that FITC influences the uptake, distribution, and 
intracellular localization of NPs. This becomes evident 
when one compares the localization of GdBNs conju-
gated with Cy5.5 [31] and those with FITC [22]. Con-
sidering this risk of experimental artifacts, we deliber-
ately used GdBNs without any fluorescent marker in 
our present study on the DSBs induction and repair, as 
well as in our earlier works on the cell survival [23, 31].
4. Methodology used to monitor DSBs damage induc-
tion and repair: detection of DSBs repair foci by 
confocal immunofluorescence microscopy currently 
represents the most sensitive method to detect DSBs 
and monitor their repair. However, one should keep 
in mind some limitations of this method. Recent evi-
dence suggests that γH2AX (histone H2AX phos-
phorylation on Ser139) alone may not always cor-
respond with DSBs. In addition to ATM-mediated 
phosphorylation, H2AX can be phosphorylated also 
by ATR kinase in response to single-stranded DNA 
formation [60–62], such as during the replication 
stress caused by the replication fork arrest. Further, 
DNA-PK mediates phosphorylation of H2AX in cells 
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during the apoptotic DNA fragmentation [52, 80]. 
Finally, γH2AX staining independent of DNA DSBs 
formation but related to nucleotide excision repair 
has previously been observed with primary human 
fibroblasts after UV irradiation [81]. In addition, it 
may be sometimes difficult to discriminate between 
true γH2AX foci and the background noise, espe-
cially in short periods of time post-irradiation (about 
2–15  min PI) that are most relevant when DSBs 
induction is concerned [82]. Hence, we used inde-
pendent immunolabelling of two DSBs markers—
γH2AX and 53BP1—in combination with high-res-
olution confocal microscopy [82]. According to our 
best knowledge, this approach increases the accuracy 
of the DSBs recognition [83–86], and has not been 
used in earlier studies.
Further experimental incompatibility between stud-
ies follow from the fact that some authors analyzed the 
DSBs foci induction early PI [22] but the others [10, 46] 
rather followed the repair process, assuming that only the 
unrepaired DNA damage would lead to cell death or at 
least prevent further cell division. Here, we studied both 
the formation of DSBs immediately (5  min) PI and the 
removal of these lesions in several periods of time PI, up 
to 24  h PI. Therefore, we significantly extend the DSBs 
experiments performed by Mowat et al. [22] and Miladi 
et al. [33] in several aspects.
Conclusions
We demonstrate that GdBNs of parameters defined 
in this study are localized in the cell cytoplasm and are 
not genotoxic. In conditions where these NPs exert sig-
nificant radioenhancing effect they affect neither the 
induction of DNA double strand breaks nor their repair 
kinetics and efficiency. While further studies are needed 
to shed more light on processes forcing the cells to die 
after the cytoplasmic damage, and on the role of NPs in 
these processes, we can reasonably hypothesize on the 
basis of our results that electron showers and ROS emit-
ted by irradiated NPs accumulated in lysosomes can dis-
integrate these organelles. This could be accompanied by 
a massive release of degradation enzymes into the cyto-
plasm and consequently auto-digestion and death of the 
cell. New super-resolution ‘nanoscopy’ techniques [77, 
87] open opportunities to test our hypothesis directly in 
future.
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